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RespirationHypoxia-inducible factor 1 (HIF-1) mediates adaptive responses to reduced oxygen availability by regulating
gene expression. A critical cell-autonomous adaptive response to chronic hypoxia controlled by HIF-1 is reduced
mitochondrial mass and/ormetabolism. Exposure of HIF-1-deﬁcient ﬁbroblasts to chronic hypoxia results in cell
death due to excessive levels of reactive oxygen species (ROS). HIF-1 reduces ROS production under hypoxic
conditions by multiple mechanisms including: a subunit switch in cytochrome c oxidase from the COX4-1 to
COX4-2 regulatory subunit that increases the efﬁciency of complex IV; induction of pyruvate dehydrogenase
kinase 1, which shunts pyruvate away from the mitochondria; induction of BNIP3, which triggers mitochondrial
selective autophagy; and induction ofmicroRNA-210,which blocks assembly of Fe/S clusters that are required for
oxidative phosphorylation. HIF-1 is also required for ischemic preconditioning and this effect may be due in part
to its induction of CD73, the enzyme that produces adenosine. HIF-1-dependent regulation of mitochondrial
metabolism may also contribute to the protective effects of ischemic preconditioning. This article is part of a
Special Issue entitled: Mitochondria and Cardioprotection.hondria and Cardioprotection.
oadway, Baltimore, MD 21205,
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The story of life on Earth is a tale of oxygen production and
utilization. Approximately 3 billion years ago, primitive single-celled
organisms evolved the capacity for photosynthesis, a biochemical
process in which photons of solar energy are captured by chlorophyll
and used to power the reaction of CO2 and H2O to form glucose and O2.
The subsequent rise in the atmospheric O2 concentration over the next
billion years set the stage for the ascendance of organisms with the
capacity for respiration, a process that consumes glucose and O2 and
generates CO2, H2O, and energy in the formof ATP. Someof these single-
celled organisms eventually took up residence within the cytoplasm of
other cells and devoted all of their effort to energy production as
mitochondria. Compared to the conversion of glucose to lactate by
glycolysis, the complete oxidation of glucose by respiration provided
such a large increase in energy production that it made possible the
evolution of multicellular organisms. Among metazoan organisms, the
progressive increase in body size during evolution was accompanied byprogressivelymore complexanatomic structures that function to ensure
the adequate delivery of O2 to all cells, ultimately resulting in the
sophisticated circulatory and respiratory systems of vertebrates.
All metazoan cells can sense and respond to reduced O2 availability
(hypoxia). Adaptive responses to hypoxia can be cell-autonomous,
such as the alterations inmitochondrialmetabolism that are described
later, or non-cell-autonomous, such as changes in tissue vasculariza-
tion (reviewed in Ref. [1]). Primary responses to hypoxia need to be
distinguished from secondary responses to sequelae of hypoxia, such
as the adaptive responses to ATP depletion that are mediated by AMP
kinase (reviewed in Ref. [2]). In contrast, recent data suggest that O2
and redox homeostasis are inextricably linked and that changes in
oxygenation are inevitably associated with changes in the levels of
reactive oxygen species (ROS), as will be discussed later.
2. HIF-1 regulates oxygen homeostasis in all metazoan species
A key regulator of the developmental and physiological networks
required for the maintenance of O2 homeostasis is hypoxia-inducible
factor 1 (HIF-1). HIF-1 is a heterodimeric transcription factor that is
composed of an O2-regulated HIF-1α subunit and a constitutively
expressed HIF-1β subunit [3,4]. HIF-1 regulates the expression of
hundreds of genes through several major mechanisms. First, HIF-1
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DNA sequences located within target genes [5]. The binding of HIF-1
results in the recruitment of co-activator proteins that activate gene
transcription (Fig. 1A). Only rarely does HIF-1 binding result in
transcriptional repression [6]. Instead, HIF-1 represses gene expres-
sion by indirect mechanisms, which are described later. Second,
among the genes activated by HIF-1 are many that encode
transcription factors [7], which when synthesized can bind to and
regulate (either positively or negatively) secondary batteries of target
genes (Fig. 1B). Third, another group of HIF-1 target genes encode
members of the Jumonji domain family of histone demethylases
[8,9], which regulate gene expression by modifying chromatin
structure (Fig. 1C). Fourth, HIF-1 can activate the transcription of
genes encoding microRNAs [10], which bind to speciﬁc mRNA
molecules and either block their translation or mediate their
degradation (Fig. 1D). Fifth, the isolated HIF-1α subunit can bind to
other transcription factors [11,12] and inhibit (Fig. 1E) or potentiate
(Fig. 1F) their activity.
HIF-1α and HIF-1β are present in all metazoan species, including
the simple roundworm Caenorhabitis elegans [13], which consists
of ~103 cells and has no specialized systems for O2 delivery. The fruit
ﬂy Drosophila melanogaster evolved tracheal tubes, which conductE 
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Fig. 1. Mechanisms by which HIF-1 regulates gene expression. (A) Top: HIF-1 binds directly
proteins suchasp300 to increasegene transcription. The codingsequence (CDS)of theseHIF-1 ta
only several rare examples inwhich HIF-1 binding leads to transcriptional repression. (B) HIF-1
either activates (TFA) or represses (TFR) the expression of secondary target genes by binding to
genes encoding proteins with histone demethylase (HDM) activity. Demethylation of histo
expression of genes within the modiﬁed chromatin. (D) HIF-1 activates transcription of genes e
degradation. (E) HIF-1α binds to the transcription factor SP1 and blocks activation of the gene
(F) HIF-1α binds to the Notch intracellular domain (NICD) and potentiates transcriptional acti
(Adapted from Ref. [50].)air into the interior of the body from which it diffuses to surroun-
ding cells. In vertebrates, the development of the circulatory and
respiratory systems was accompanied by the appearance of HIF-2α,
which is also O2-regulated and heterodimerizes with HIF-1β [14] but
is only expressed in a restricted number of cell types [15], whereas
HIF-1α and HIF-1β are expressed in all human andmouse tissues [16].
In Drosophila, the ubiquitously expressed HIF-1α ortholog is desig-
nated Similar [17] and the paralogous gene that is expressed
speciﬁcally in tracheal tubes is designated Trachealess [18].
3. HIF-1 activity is regulated by oxygen
In the presence of O2, HIF-1α and HIF-2α are subjected to
hydroxylation by prolyl-4-hydroxylase domain proteins (PHDs) that
use O2 and α-ketoglutarate as substrates and generate CO2 and
succinate as by-products [19]. Prolyl hydroxylation is required for
binding of the von Hippel–Lindau protein, which recruits a ubiquitin–
protein ligase that targets HIF-1α and HIF-2α for proteasomal
degradation (Fig. 2). Under hypoxic conditions, the rate of hydroxyl-
ation declines and the non-hydroxylated proteins accumulate. HIF-1α
transactivation domain function is also O2-regulated [20,21]. Factor
inhibiting HIF-1 (FIH-1) represses transactivation domain function [22]C 
F 
to target genes at a cis-acting hypoxia response element (HRE) and recruits co-activator
rget genes encodesproteins thatmediate adaptive responses tohypoxia.Bottom: There are
binds directly to and transactivates a gene that encodes a transcription factor (TF), which
its cognate transcription factor binding site (TFBS). (C) HIF-1 activates the transcription of
nes alters chromatin structure, which either decreases (as illustrated) or increases the
ncodingmicroRNAs that bind to mRNAs and either block their translation or induce their
encoding the mismatch DNA repair protein MSH2, thereby functioning as a co-repressor.
vation of Notch target genes, thereby functioning as a co-activator.
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the binding of the co-activators p300 and CBP [23].
When cells are acutely exposed to hypoxic conditions, the
generation of ROS at complex III of themitochondrial electron transport
chain (ETC) increases and is required for the inductionofHIF-1αprotein
levels [24].More than a decade after these observationswereﬁrstmade,
the precisemechanism bywhich hypoxia increases ROS generation and
by which ROS induces HIF-1α accumulation remains unknown.
However, the prolyl and asparaginyl hydroxylases contain Fe2+ in
their active site and oxidation to Fe3+ would block their catalytic
activity. Since O2 is a substrate for the hydroxylation reaction, anoxia
also results in a loss of enzyme activity. However, the concentration at
whichO2becomes limiting for prolyl or asparaginyl hydroxylase activity
in vivo is not known.
4. HIF-1 regulates the balance between oxidative and
glycolytic metabolism
All metazoan organisms depend on mitochondrial respiration as
the primary mechanism for generating sufﬁcient amounts of ATP to
maintain cellular and systemic homeostasis. Respiration, in turn, is
dependent on an adequate supply of O2 to serve as the ﬁnal electron
acceptor in the ETC. In this process, electrons are transferred from
complex I (or complex II) to complex III, then to complex IV, and
ﬁnally to O2, which is reduced to water. This orderly transfer of
electrons generates a proton gradient across the inner mitochondrial
membrane that is used to drive the synthesis of ATP. At each step of
this process, some electrons combine with O2 prematurely, resulting
in the production of superoxide anion, which is reduced to hydrogen
peroxide through the activity of mitochondrial superoxide dismutase.
The efﬁciency of electron transport appears to be optimized to the
physiological range of O2 concentrations, such that ATP is produced
without the production of excess superoxide, hydrogen peroxide, and
other ROS at levels that would result in the increased oxidation of
cellular macromolecules and subsequent cellular dysfunction or
death. In contrast, when O2 levels are acutely increased or decreased,
an imbalance between O2 and electron ﬂow occurs, which results in
increased ROS production.
When cells such as mouse embryo ﬁbroblasts (MEFs) are acutely
subjected to hypoxia, e.g. a reduction of ambient O2 concentration from
20% to 0.5–1%, ROS levels increase within minutes. However, when
MEFs are maintained at 0.5–1% O2 for several days, ROS levels actually
decrease relative to cells that are maintained at 20% O2 [25,26]. WhenFig. 2. Negative regulation ofHIF-1 activity by oxygen. Top: In the presence of O2: prolyl hydroxy
ubiquitin–protein ligase that targets HIF-1α for proteasomal degradation; asparaginyl hydroxyl
conditions, the hydroxylation reactions are inhibited, leading to decreased VHL binding and prthese experiments are performed withMEFs that are homozygous for a
knockout (KO) allele at the locus encoding HIF-1α, chronic hypoxia
causes ROS levels to increase rather than decrease, resulting in cell
death within several days. Treatment of the cells with a free radical
scavenger signiﬁcantly increases the survival of the KO MEFs.
Remarkably, HIF-1α KO MEFs cultured at 1% O2 have higher ATP
levels thanwild-typeMEFs cultured at 20% O2, demonstrating that O2 is
not limiting for oxidative phosphorylation under these conditions [26].
However, continued high rates of respiration of KO cells under hypoxic
conditions are associated with the production of lethal levels of ROS.
Thus, the primary adaptive signiﬁcance of the HIF-1-dependent switch
from oxidative to glycolytic metabolism under hypoxic conditions is
not maintenance of ATP levels (this is the purview of AMP kinase) but
rather the maintenance of redox homeostasis.
MEFs require HIF-1 activity to make two critical metabolic
adaptations to chronic hypoxia. First, HIF-1 activates the gene
encoding pyruvate dehydrogenase (PDH) kinase 1 (PDK1), which
phosphorylates and inactivates the catalytic subunit of PDH, the
enzyme that converts pyruvate to acetyl coenzyme A (AcCoA) for
entry into the mitochondrial tricarboxylic acid (TCA) cycle [25].
Second, HIF-1 activates the gene encoding BNIP3, a member of the
Bcl-2 family of mitochondrial proteins, which triggers selective
mitochondrial autophagy [26]. Interference with the induction of
either of these proteins in hypoxic cells results in increased ROS
production and increased cell death. Overexpression of either PDK1 or
BNIP3 rescues HIF-1α-null MEFs. By shunting pyruvate away from the
mitochondria, PDK1 decreases ﬂux through the ETC and thereby
counteracts the reduced efﬁciency of electron transport under
hypoxic conditions, which would otherwise increase ROS production.
PDK1 functions cooperatively with the product of another HIF-1
target gene, LDHA [27], which converts pyruvate to lactate, thereby
further reducing available substrate for the PDH reaction.
PDK1 effectively reduces ﬂux through the TCA cycle and thereby
reduces ﬂux through the ETC in cells that primarily utilize glucose as a
substrate for oxidative phosphorylation. However, PDK1 is predicted
to have little effect on ROS generation in cells that utilize fatty acid
oxidation as their source of AcCoA. Hence another strategy to reduce
ROS generation under hypoxic conditions is selective mitochondrial
autophagy [26]. MEFs reduce their mitochondrial mass and O2
consumption by N50% after only two days at 1% O2. BNIP3 competes
with Beclin-1 for binding to Bcl-2, thereby freeing Beclin-1 to activate
autophagy. Using short hairpin RNAs to knockdown expression of
BNIP3, Beclin-1, or Atg5 (another component of the autophagylation ofHIF-1α leads to binding of the vonHippel–Lindau protein (VHL),which recruits a
ation of HIF-1α blocks the binding of the co-activator protein p300. Bottom: Under hypoxic
otein stabilization as well as increased p300 binding and transcriptional activation.
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induced reductions in mitochondrial mass and O2 consumption as a
result of failure to induce autophagy [26]. HIF-1-regulated expression
of BNIP3L also contributes to hypoxia-induced autophagy [28].
Remarkably, mice heterozygous for the HIF-1α KO allele have a
signiﬁcantly increased ratio of mitochondrial:nuclear DNA in their
lungs (even though this is the organ that is exposed to the highest O2
concentrations), indicating that HIF-1 regulates mitochondrial mass
under physiological conditions in vivo [26]. In contrast to the selective
mitochondrial autophagy that is induced in response to hypoxia as
described previously, autophagy (of unspeciﬁed cellular components)
induced by anoxia does not require HIF-1, BNIP3, or BNIP3L, but is
instead regulated by AMP kinase [29].
Another demonstration that HIF-1 regulates mitochondrial ROS
production over the physiological range of O2 concentrations was the
ﬁnding that cells express the COX4-1 regulatory subunit of cyto-
chrome c oxidase (ETC complex IV) under aerobic conditions but
switch to the COX4-2 subunit under hypoxic conditions. HIF-1
activates transcription of the genes encoding COX4-2 and LON, a
mitochondrial protease that is required for degradation of COX4-1
[30]. It appears that the subunit switch is designed to optimize COX
activity under hypoxic conditions. These results suggest that under
conditions of chronic hypoxia, ETC complex IV can also become a
source of increased ROS production if the COX4 subunit switch does
not occur.
Most recently, another mechanism has been reported by which
HIF-1 can block bothmitochondrial respiration and ETC activity. HIF-1
activates the transcription of the microRNA miR-210 in many cell
types [10,31] andmiR-210was shown to block expression of the iron–
sulfur cluster assembly proteins ISCU1/2, which are required for the
function of the TCA cycle enzyme aconitase and ETC complex I [32].
The multiplicity of HIF-1-mediated mechanisms identiﬁed so far by
which cells regulate mitochondrial metabolism in response to changes
in cellular O2 concentration (Fig. 3) suggests that this is a critical
adaptive response to hypoxia. The fundamental nature of this
physiological response is underscored by the fact that yeast also switch
COX4 subunits in an O2-dependent manner but do so by an entirely
different molecular mechanism [33], since yeast do not have a HIF-1α
homologue. Thus, it appears that by convergent evolution both
unicellular and multicellular eukaryotes possess mechanisms by
which they modulate mitochondrial metabolism to maintain redox
homeostasis despite changes in O2 availability. Indeed, it is the balance
between energy, oxygen, and redox homeostasis that represents the
key to life with oxygen.
5. HIF-1 is a critical mediator of hypoxic and ischemic
cardiac preconditioning
Exposure of the heart to one or more brief (~5-min) episodes of
ischemia protects against myocardial cell death following a prolonged
(~30-min) episode of ischemia, a phenomenon known as ischemic
preconditioning [34]. Preconditioning results in two phases of
protection, an acute or early phase immediately following the
preconditioning stimulus and lasting no more than several hours
and a delayed or late phase starting ~24 h after the preconditioning
stimulus and lasting for several days [35]. Perfusion of the heart with
hypoxic blood [36] or adenosine analogues [37] is sufﬁcient to induce
acute preconditioning. Chronic exposure of rats to ambient hypoxia
(3 weeks at 10% O2) also protects the heart against ischemia–
reperfusion injury [38].
Exposure of mice to alternating cycles of ambient hypoxia (6% O2 for
6 min) and reoxygenation (21% O2 for 6 min) for 1 h induces delayed
cardiac preconditioning and this effect is lost in Hif1a+/−mice that are
heterozygous for the HIF-1α KO allele [39]. This protective effect
appears to bemediated at least in part by the expression (in the kidney)
and secretion into the bloodstream of the hormone erythropoietin(EPO), which is the product of the ﬁrst identiﬁed HIF-1 target gene [3].
Direct administration of EPO into isolated perfused hearts results in
acute protection against ischemia–reperfusion injury [40].
When isolated perfused hearts from wild-type mice are subjected
to two cycles of global no-ﬂow ischemia (5 min) and reperfusion
(5 min) as an acute preconditioning stimulus, they are protected
against subsequent prolonged ischemia (30 min) and reperfusion,
whereas this protection is completely lost in hearts from Hif1a+/−
mice [41]. In contrast, hearts fromHif1a+/−mice are protected against
ischemia–reperfusion injury when adenosine perfusion is used as the
acute preconditioning stimulus, indicating a speciﬁc defect in
responding to ischemia [41]. Inhibition of HIF-1α expression by
transduction of small interfering RNAs into the heart also blocks
ischemic preconditioning [42].
Adenosine levels increase in hearts subjected to ischemic
preconditioning and pretreatment with adenosine receptor antago-
nists blocks the protective effect of ischemic preconditioning [43],
whereas treatmentwith adenosine receptor agonists mimics ischemia
as a preconditioning stimulus [35,43]. Adenosine is formed from
extracellular ATP through the activity of two enzymes: Ectonucleoside
triphosphate diphosphohydrolase 1 (ENTPD1, also known as CD39)
converts ATP to ADP and then to AMP; and ecto-5′-nucleotidase
(NT5E, also known as CD73) converts AMP to adenosine. CD73
expression is induced in hypoxic cells and this involves direct binding
of HIF-1 to the Nt5e gene [44]. CD73 KO mice lack ischemic
preconditioning [45]. Remarkably, hearts from Hif1a+/− mice are
protected against ischemia–reperfusion injury by adenosine perfusion
[41]. Taken together, these results suggest that production of
adenosine during ischemic preconditioning is dependent on normal
levels of HIF-1 and that loss of HIF-1 activity leads to insufﬁcient
production of adenosine, which in turn leads to the loss of
preconditioning. Adenosine administration allows the defect in HIF-
1-dependent adenosine production to be bypassed, thereby resulting
in the rescue of ischemic Hif1a+/− hearts.
6. Does regulation of mitochondria by HIF-1 also contribute
to preconditioning?
As described previously, a major role of HIF-1 is to prevent
excess mitochondrial ROS production under hypoxic conditions,
suggesting that HIF-1 activation during ischemic preconditioning
might protect the heart by inhibiting mitochondrial metabolism.
Yet, as in the case of the adenosine pathway, the known mecha-
nisms by which HIF-1 regulates mitochondrial respiration require
transcriptional activation of target genes and the subsequent
synthesis of the target gene products. However, a preconditioning
protocol consisting of two cycles of 5-min ischemia/5-min reperfu-
sion followed by a 30-min ischemic insult provides less than one
hour for a protective response to be put in play before reperfusion
occurs. Is this enough time?
An alternative model is that HIF-1α enters the mitochondria and
directly alters mitochondrial metabolism, presumably by a mecha-
nism that is independent of its known roles as a transcription factor.
This proposal is not as radical as it seems, because an increasing
number of transcription factors have been found in the mitochondria,
including p53 [46], glucocorticoid receptor [47], and STAT3, which
promotes oxidative phosphorylation by an undetermined mechanism
[48]. In support of this model, a recent study found HIF-1α in the
mitochondria of cultured cardiac myocytes subjected to a “precondi-
tioning stimulus” consisting of 4 cycles of 1-hour hypoxia and 1-hour
reoxygenation [49]. No speciﬁc effects of HIF-1α on mitochondrial
metabolism were reported. Since this cell culture model is of limited
relevance to the study of ischemic cardiac preconditioning, further
studies are required to more rigorously test the intriguing possibility
that HIF-1αmediates preconditioning via direct effects on mitochon-
drial metabolism.
Fig. 3. Regulation of mitochondrial metabolism by HIF-1. Acute hypoxia leads to increased mitochondrial generation of reactive oxygen species (ROS). Decreased O2 and increased
ROS levels lead to decreased HIF-1α hydroxylation (see Fig. 2) and increased HIF-1-dependent transcription of genes encoding proteins (LDHA, PDK1, BNIP3, COX4-2, and LON) or
microRNA (miR-210) that reduce mitochondrial respiration and ROS production.
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